The CAD group also exhibited significantly elevated levels of fasting blood glucose (6.33 ± 2.50 vs. 4.91 ± 0.58, P < 0.001), total cholesterol (4.25 ± 1.04 vs. 3.87 ± 0.88, P < 0.001), triglycerides (1.69 ± 1.12 vs. 1.14 ± 0.37, P < 0.001), low-density lipoprotein (2.60 ± 0.91 vs. 2.25 ± 0.73, P < 0.001), and fibrinogen (3.12 ± 0.95 vs. 2.81 ± 0.84, P < 0.001), along with lower levels of high-density lipoprotein (1.03 ± 0.28 vs. 1.10 ± 0.30, P < 0.001) and albumin (40.50 ± 4.47 vs. 41.92 ± 3.76, P < 0.001). This evidence concerns the gene ALB and coronary artery disorder.